These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 5710820)

  • 21. [Biological criteria for determination of recovery from tuberculosis].
    Lucchesi M; Mancini P
    Lotta Tuberc; 1971; 41(4):547-53. PubMed ID: 5004580
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnostic importance of the quantitative determination of the extent of bacteria excretion during the chemotherapy process in chronic destructive pulmonary tuberculosis].
    Khomenko AG; Kozulitsyna TI; Kaminskaia AA; Andrusskaia MK; Khlopovskiĭ SG
    Probl Tuberk; 1981 Jun; (6):17-22. PubMed ID: 7024984
    [No Abstract]   [Full Text] [Related]  

  • 23. [The curability of recently diagnosed sputum-positive, cavitary pulmonary tuberculosis].
    Janczy S
    Folia Med Cracov; 1968; 10(4):533-91. PubMed ID: 5733789
    [No Abstract]   [Full Text] [Related]  

  • 24. [Contagiousness of tuberculosis patients undergoing chemotherapy].
    Medici TC; Rieder H
    Schweiz Med Wochenschr; 1981 Aug; 111(34):1252-5. PubMed ID: 6792701
    [No Abstract]   [Full Text] [Related]  

  • 25. [Is there a correlation between disease duration and total therapeutic result].
    Sutalo I
    Tuberkuloza; 1967; 19(5):655-7. PubMed ID: 5188401
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of tuberculosis patients with massive bacterial excretion].
    Gavril'ev SS; Vinokurova MK
    Probl Tuberk; 1997; (2):17-8. PubMed ID: 9235572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Late, sporadic and paucibacillary elimination of mycobacteria in patients with stable sequelae after chemotherapy].
    Barbu Z; Barbu E; Alexa M; Jozefovics F; Szylveszter I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1974; 23(4):361-9. PubMed ID: 4377685
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anatomoclinical study of the incidence of some factors of chronicization of treated pulmonary tuberculosis].
    Diaconiţă G; Ionescu J; Luţescu L
    Ftiziologia; 1973; 22(5):485-92. PubMed ID: 4751364
    [No Abstract]   [Full Text] [Related]  

  • 30. [To the problem of abacillary caverns in patients with pulmonary tuberculosis].
    Khudushina TA; Voloshina EP
    Probl Tuberk; 2003; (3):48-50. PubMed ID: 12744066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness of initial intermittent chemotherapy with classical tuberculostatic drugs, evaluated by study of the negation of sputum cultures].
    Anastasatu C; Kaufman S; Dinulică E; Negulescu E; Kercea V
    Ftiziologia; 1971; 20(3):233-8. PubMed ID: 5164058
    [No Abstract]   [Full Text] [Related]  

  • 32. [Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
    Augé C; Lecocguic Y; Touaty E; Bussi S; Pariente R
    Rev Fr Mal Respir; 1982; 10(6):391-9. PubMed ID: 6819611
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of biological assay in the detection of "latent" bacteria release during chemotherapy].
    Posperov VV; Pashkov IuN; Lobchenko AI
    Probl Tuberk; 1982 Aug; (8):62-6. PubMed ID: 6815644
    [No Abstract]   [Full Text] [Related]  

  • 34. [The clinical features of tuberculosis in children and adolescents excreting drug-resistant Mycobacterium tuberculosis strains].
    Bekembaeva GS; Serikbaeva KS; Kastypkaeva DV
    Probl Tuberk Bolezn Legk; 2009; (6):13-6. PubMed ID: 19642567
    [No Abstract]   [Full Text] [Related]  

  • 35. [Disappearance rate of bacteria as a parameter of the efficacy of tuberculostatic treatment of cavitating lung tuberculosis].
    Seri I
    Prax Pneumol; 1972 Jan; 26(1):12-22. PubMed ID: 5011607
    [No Abstract]   [Full Text] [Related]  

  • 36. [Early results of pulmonary tuberculosis therapy in patients over 50-year-old].
    Justyńska-Lukoska R; Jórdeczka S; Szkodowa M
    Gruzlica; 1967 May; 35(5):429-34. PubMed ID: 6056256
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ambulatory treatment of patients with tuberculosis. Its present promotion and problems].
    Kreis B
    Presse Med (1893); 1970 May; 78(27):1211-2. PubMed ID: 5421542
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effectiveness of prolonged antibacterial therapy in newly detected patients with active pulmonary tuberculosis].
    Kuropatkin IF; Chuprova KP
    Probl Tuberk; 1967; 45(9):32-5. PubMed ID: 5606475
    [No Abstract]   [Full Text] [Related]  

  • 39. [Healing of the lung caverns based on data from bacteriological and morphological studies].
    Vorozhtsova MP
    Probl Tuberk; 1988; (1):35-7. PubMed ID: 3129714
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experiences with ambulatory therapy of infectious pulmonary tuberculosis].
    Kropp R; Dissmann E
    Prax Klin Pneumol; 1983 Feb; 37(2):63-6. PubMed ID: 6835925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.